牛牛AI助理已提取核心訊息
Merck & Co. officer Caroline A. Litchfield is set to sell 38,291 shares of the company's common stock on February 14, 2024. The shares, valued at approximately $4,805,520.50, were acquired on the same date through the exercise of options under a registered plan. The transaction will be conducted with the issuer, and payment for the securities will be made in cash. This announcement does not include any other transactions in the past three months, as there is nothing to report in that period.
Merck & Co. officer Caroline A. Litchfield is set to sell 38,291 shares of the company's common stock on February 14, 2024. The shares, valued at approximately $4,805,520.50, were acquired on the same date through the exercise of options under a registered plan. The transaction will be conducted with the issuer, and payment for the securities will be made in cash. This announcement does not include any other transactions in the past three months, as there is nothing to report in that period.
默沙東公司高管卡羅琳·利奇菲爾德定於2024年2月14日出售公司38,291股普通股。這些股票價值約4,805,520.50美元，於同日通過行使註冊計劃下的期權收購。該交易將與發行人進行，證券的付款將以現金支付。該公告不包括過去三個月中的任何其他交易，因爲在此期間沒有可報告的任何其他交易。
默沙東公司高管卡羅琳·利奇菲爾德定於2024年2月14日出售公司38,291股普通股。這些股票價值約4,805,520.50美元，於同日通過行使註冊計劃下的期權收購。該交易將與發行人進行，證券的付款將以現金支付。該公告不包括過去三個月中的任何其他交易，因爲在此期間沒有可報告的任何其他交易。
有用
沒用